Transact Tech Stock Price, News & Analysis

TransAct Technologies has completed a major upgrade of its BOHA! Terminal 2 system across 1,400 locations of a leading national convenience store chain during Q1 2025. The customer, a long-time BOHA! user, has implemented the upgrade across their entire store network, with many locations receiving two devices.

The BOHA! Terminal 2 enhances foodservice operations by:

• Streamlining key workflows
• Improving employee task completion speed and accuracy
• Delivering measurable labor savings
• Enhancing food safety
• Reducing food waste

The convenience store chain, which also operates national brand restaurants within their locations, uses BOHA! solutions to maintain consistent food safety processes and operational efficiency across all brands. The technology will be showcased at the National Restaurant Association Show in May 2025.

TransAct Technologies (TACT) has secured a significant three-year contract with a national healthcare services provider to implement its BOHA!® ecosystem across 131 contracted hospitals. The agreement includes the deployment of 229 BOHA! Terminal 2 devices for date code labeling, with 34 locations additionally implementing BOHA! Timer, BOHA! Temp, and BOHA! Sense solutions, comprising 68 BOHA! Gateways and 770 BOHA! Sensors.

The comprehensive deal encompasses Premier Express Warranty, dissolvable labels, installation, and training services. This partnership aims to enhance food safety and operational efficiency across the customer's hospital division, following successful trial and pilot programs.

TransAct Technologies (TACT) reported preliminary Q4 and full year 2024 results, with Q4 net sales of $10.2 million, down 23% year-over-year. The company sold over 1,600 terminals in Q4 2024, achieving an eight-quarter CAGR of 42% - the highest quarterly number since 2020.

Q4 2024 highlights include a net loss of $(8.0) million, or $(0.79) per share, including a $7.3 million non-cash tax charge. FST recurring revenue was $2.7 million, down 15% year-over-year. Gross profit margin decreased to 44.2% from 48.0% in Q4 2023.

For full year 2024, net sales declined 40% to $43.4 million, with a net loss of $(9.9) million. Looking ahead, TransAct projects 2025 net sales between $47-52 million and adjusted EBITDA between $0 and negative $2.0 million. The company's strategic review process remains active as management focuses on increasing shareholder value.

TransAct Technologies (Nasdaq: TACT) has announced it will release its fourth quarter and full year 2024 financial results after market close on March 13, 2025. The company will host a conference call and webcast at 4:30 p.m. ET on the same day.

Investors can access the live call via phone at 877-704-4453 (Conference ID: 13751789) or through the company's website. A replay will be available approximately 2 hours after the call until March 27, 2025, at 844-512-2921 with the same pin.

TransAct Technologies (Nasdaq: TACT) released preliminary financial results for Q3 2024, reporting net sales of $10.9 million, down 6% sequentially and 37% year-over-year. The company sold 1,355 BOHA! Terminals in the quarter and added 12 new FST customers, contributing to 2,400 potential Terminal 2 sales opportunities. Despite these gains, the company faced a net loss of $(551) thousand or $(0.06) per diluted share, compared to a net income of $906 thousand or $0.09 per diluted share in Q3 2023. Gross profit was $5.2 million with a 48.1% margin, down from $8.9 million and a 51.9% margin in Q3 2023. EBITDA was negative $(533) thousand, and adjusted EBITDA was negative $(204) thousand. The company maintains its full-year 2024 net sales outlook at $43-$45 million and adjusted EBITDA between negative $1 million and negative $2 million.

TransAct Technologies (Nasdaq: TACT) announced it will release its third quarter 2024 financial results after market close on November 7, 2024. The company will host a conference call and simultaneous webcast at 4:30 p.m. ET the same day. The conference call will be accessible via phone (877-704-4453, ID: 13749888) and through their website. A replay will be available until November 21, 2024, at 844-512-2921 with the same PIN.

TransAct Technologies (Nasdaq: TACT) announced its participation in two major Las Vegas events: NACS 2024 and G2E 2024, from October 8th to 10th. At NACS, TransAct will showcase its BOHA!® suite for convenience store fresh food operations at booth #C6463, featuring the new BOHA! Terminal 2 and various labeling solutions.

At G2E 2024, TransAct will present its Epic casino & gaming printers, Epicentral promotional software, and BOHA! foodservice technology at booth #2423. The company will highlight its Epicentral SE solution integrated with CasinoTrac's SlotSUITE. Recent deployment results show significant improvements in carded play (58.6% increase), rated coin-in (21% increase), and overall coin-in (3% increase).

CasinoTrac and TransAct have reported impressive results from a six-month deployment of their SlotSUITE system, powered by Epicentral SE, at a large regional casino in the American Southwest. The implementation, covering over 2,500 games, showed significant improvements in key performance areas:

- Carded/Rated Play increased by 58.6%, from 17% to 29%
- Rated Coin-In rose by 21% on upgraded games
- Overall Coin-In increased by 3% across the entire floor
- Rated WPU (Win Per Unit) grew by 39% on SlotSUITE-enhanced games
- Overall WPU increased by 8% across the entire gaming floor

The SlotSUITE system integrates TransAct's Epicentral SE with CasinoTrac's PromoTrac, offering a single-wire solution for enhanced player engagement and streamlined operations.

TransAct Technologies (Nasdaq: TACT) announced preliminary financial results for Q2 2024, with net sales of $11.6M, a 9% sequential increase but a 42% decline YoY. The company sold 1,500 terminals, up 64% sequentially, and added 13 new customers to its BOHA! platform.

FST recurring revenue was $2.8M, up 15% sequentially and 12% YoY. The gross profit was $6.1M with a 52.7% margin. However, the operating loss was $(438)K, an improvement from Q1 2024's $(1.3)M loss, but down from Q2 2023's $1.2M income. Net loss stood at $(319)K, improving from $(1.0)M in Q1 2024 but down from $765K in Q2 2023. Adjusted net loss was $(319)K, compared to $2.2M adjusted net income YoY.

EBITDA was negative $190K, while adjusted EBITDA was $89K. For the full year 2024, TransAct expects net sales between $45M and $50M and adjusted EBITDA between negative $1M and negative $2M, improving from prior estimates.